Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crest TV ads

This article was originally published in The Tan Sheet

Executive Summary

P&G breaks two spots for whitening toothpaste formulas Oct. 20. One shows a toothbrush polishing the American Dental Association seal of acceptance while an announcer says, "Who believes Crest Extra Whitening really works? They do," referring to ADA. "It's the first and only toothpaste that's ADA-accepted for whitening by polishing away surface stains," the ad continues. Product packaging also bears the ADA seal (1"The Tan Sheet" Oct. 18, p. 8). The ad for Crest MultiCare Whitening stresses product benefits, stating, "Now the toothpaste that fights cavities and dingy tartar buildup, freshens breath and removes plaque with every brushing is so complete it whitens too." The commercial concludes with the tagline: "New Crest MultiCare Whitening. Don't be left in the dark." The product was launched in September

You may also be interested in...



Crest Extra Whitening ADA Approval Featured In New Ads, Packaging

New Crest Extra Whitening print and TV spots set to drop the week of Oct. 18 emphasize the product's status as the first and only OTC whitening toothpaste to meet ADA standards for whitening effectiveness, safety and cavity prevention. The advertising is being handled by New York City-based DMB&B.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090461

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel